Newsletter | October 15, 2020

10.15.20 -- The Intriguing FDA News You May Have Missed

Featured Editorial
Industry Insights
The Insource vs. Outsource Dilemma

Prior to making critical capacity decisions, a small biotech company completed an economic evaluation of manufacturing options to ensure it was selecting the best strategy for its manufacturing. Discover the critical elements of this analysis that may help to balance your assessment.

Standing Out In The Crowded Biopharma CDMO Market

This presentation addresses what motivates drug innovators to outsource, who is involved in service provider selection, and which attributes have the greatest influence on CDMO selection.

News Headlines

October 20, 2020 | 8:00 a.m. CEST; 10:00 a.m. EDT

Technical improvements related to cryogenic electron microscopy (cryo-EM) have triggered a revolution in structural biology and made single-particle cryo-EM the dominant discipline for determining structures. Cryo-EM has opened new opportunities to determine large and complex molecules but has also introduced new challenges for the purification of samples.